Using data from the Komodo Healthcare Map database, the study examined 195,915 adults who began GLP-1 agonist treatment in 2021
Comhair SA, Xu W, Ghosh S, et al
However, with proper treatment and management, many people with MS are able to lead fulfilling and productive lives
While launch brands may offer payer rebates to improve coverage, they also frequently deploy patient support programs that improve patient access while payer coverage ramps up
A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: The ERGO (etomoxir for the recovery of glucose oxidation) study
Cannot redeclare control with same name "grid_3_cta_background_hover_position"